BEAT (BEAT) Stock Price & Analysis
BEAT (BEAT) closed at USD 0.43 on Thursday, October 15, 2026, up 9.82% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.43; the Oct 15, 2026 session ranged USD 0.4–0.44 on volume of 1,209,398 shares. Market capitalization is —, with a 52-week range of USD 0.36–4 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BEAT.md
Key facts (BEAT)
- Total return with dividends: 1Y -75.0% vs S&P 500 +18.1%; 5Y -89.8% vs S&P 500 +85.1%.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (BEAT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Operating income | -$2.3M | -$13.0M | -$15.3M | -$19.9M | -$21.1M | -$20.4M |
| Net income | -$4.4M | -$13.0M | -$14.6M | -$19.4M | -$21.0M | -$20.3M |
| EPS (diluted) | -$1.03 | -$1.59 | -$0.72 | -$0.73 | -$0.62 | — |
| Free cash flow | — | -$9.9M | -$12.3M | -$14.7M | -$14.6M | -$14.0M |
| Cash + short-term investments | $13.2M | $3.6M | $16.2M | $2.4M | $4.4M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (BEAT)
Total return (dividends reinvested) (BEAT)
| 1Y (from 2025-10-16) | 5Y (from 2021-11-08) | |
|---|---|---|
| Total return | -75.0% | -89.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -75.2% | -37.1% |
| Volatility (annualized) | 150.6% | 109.1% |
| Max drawdown | -89.5% (Dec 2025→Sep 2026) | -93.8% (Oct 2022→Sep 2026) |
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.43 |
|---|---|
| Change | ▲ 9.82% (up) |
| Previous Close | USD 0.43 |
| Open | USD 0.43 |
| Day Range | USD 0.4 – 0.44 |
| 52-Week Range | USD 0.36 – 4 |
| Volume | 1,209,398 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BEAT)
Nexqual's technical model rates BEAT "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.85 (neutral) |
| vs SMA50 | Below (USD 0.46) |
| MACD | -0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATRC | AtriCure, Inc. | USD 57.78 | ▲ 1.6% |
| SUPN | Supernus Pharmaceuticals, Inc. | USD 39.57 | ▼ 5.81% |
| KALA | KALA BIO, Inc. | USD 0.19 | ▼ 26.08% |
| INGN | Inogen, Inc | USD 6.3 | ▼ 0.71% |
| VNDA | Vanda Pharmaceuticals Inc. | USD 4.24 | ▼ 1.4% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt